PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BRGNX vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BRGNX and JNJ is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

BRGNX vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Russell 1000 Large-Cap Index Fund (BRGNX) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

250.00%300.00%350.00%400.00%AugustSeptemberOctoberNovemberDecember2025
390.00%
268.85%
BRGNX
JNJ

Key characteristics

Sharpe Ratio

BRGNX:

2.16

JNJ:

-0.35

Sortino Ratio

BRGNX:

2.86

JNJ:

-0.41

Omega Ratio

BRGNX:

1.40

JNJ:

0.95

Calmar Ratio

BRGNX:

3.31

JNJ:

-0.31

Martin Ratio

BRGNX:

13.29

JNJ:

-0.79

Ulcer Index

BRGNX:

2.11%

JNJ:

6.88%

Daily Std Dev

BRGNX:

12.99%

JNJ:

15.48%

Max Drawdown

BRGNX:

-34.59%

JNJ:

-52.60%

Current Drawdown

BRGNX:

-1.76%

JNJ:

-14.32%

Returns By Period

In the year-to-date period, BRGNX achieves a 2.28% return, which is significantly higher than JNJ's 1.67% return. Over the past 10 years, BRGNX has outperformed JNJ with an annualized return of 12.16%, while JNJ has yielded a comparatively lower 6.72% annualized return.


BRGNX

YTD

2.28%

1M

2.50%

6M

10.14%

1Y

25.39%

5Y*

13.68%

10Y*

12.16%

JNJ

YTD

1.67%

1M

1.58%

6M

-3.46%

1Y

-5.91%

5Y*

2.52%

10Y*

6.72%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BRGNX vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BRGNX
The Risk-Adjusted Performance Rank of BRGNX is 8989
Overall Rank
The Sharpe Ratio Rank of BRGNX is 8989
Sharpe Ratio Rank
The Sortino Ratio Rank of BRGNX is 8787
Sortino Ratio Rank
The Omega Ratio Rank of BRGNX is 8888
Omega Ratio Rank
The Calmar Ratio Rank of BRGNX is 9191
Calmar Ratio Rank
The Martin Ratio Rank of BRGNX is 9191
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 2626
Overall Rank
The Sharpe Ratio Rank of JNJ is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 2222
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 2323
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 2828
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 2929
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BRGNX vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Russell 1000 Large-Cap Index Fund (BRGNX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BRGNX, currently valued at 2.16, compared to the broader market-1.000.001.002.003.004.002.16-0.35
The chart of Sortino ratio for BRGNX, currently valued at 2.86, compared to the broader market0.005.0010.002.86-0.41
The chart of Omega ratio for BRGNX, currently valued at 1.40, compared to the broader market1.002.003.004.001.400.95
The chart of Calmar ratio for BRGNX, currently valued at 3.31, compared to the broader market0.005.0010.0015.0020.003.31-0.31
The chart of Martin ratio for BRGNX, currently valued at 13.29, compared to the broader market0.0020.0040.0060.0080.0013.29-0.79
BRGNX
JNJ

The current BRGNX Sharpe Ratio is 2.16, which is higher than the JNJ Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of BRGNX and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
2.16
-0.35
BRGNX
JNJ

Dividends

BRGNX vs. JNJ - Dividend Comparison

BRGNX's dividend yield for the trailing twelve months is around 1.12%, less than JNJ's 3.34% yield.


TTM20242023202220212020201920182017201620152014
BRGNX
iShares Russell 1000 Large-Cap Index Fund
1.12%1.15%1.43%1.45%1.19%1.35%1.84%2.01%1.95%2.16%2.05%1.71%
JNJ
Johnson & Johnson
3.34%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

BRGNX vs. JNJ - Drawdown Comparison

The maximum BRGNX drawdown since its inception was -34.59%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for BRGNX and JNJ. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-1.76%
-14.32%
BRGNX
JNJ

Volatility

BRGNX vs. JNJ - Volatility Comparison

iShares Russell 1000 Large-Cap Index Fund (BRGNX) and Johnson & Johnson (JNJ) have volatilities of 5.15% and 5.21%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%AugustSeptemberOctoberNovemberDecember2025
5.15%
5.21%
BRGNX
JNJ
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab